J And J Company Profile
What is the competitive landscape for J AND J
J AND J has twelve approved drugs.
Summary for J And J
| US Patents: | 0 |
| Tradenames: | 10 |
| Ingredients: | 8 |
| NDAs: | 12 |
Drugs and US Patents for J And J
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017690-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| J And J | MICRODERM | chlorhexidine gluconate | SPONGE;TOPICAL | 072295-001 | Feb 28, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| J And J Consumer Inc | ZYRTEC | cetirizine hydrochloride | SOLUTION;ORAL | 020346-001 | Sep 27, 1996 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| J And J Consumer Inc | IBUPROFEN | ibuprofen | TABLET;ORAL | 070081-001 | Jun 16, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| J And J | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 060618-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for J And J
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | 5,248,505 | ⤷ Start Trial |
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | 5,716,641 | ⤷ Start Trial |
| J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017694-001 | Approved Prior to Jan 1, 1982 | 3,714,159 | ⤷ Start Trial |
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | 5,489,436 | ⤷ Start Trial |
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | 5,679,376 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for J AND J drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Syrup | 5 mg/5 mL | ➤ Subscribe | 2007-03-19 |
| ➤ Subscribe | Chewable Tablets | 5 mg and 10 mg | ➤ Subscribe | 2005-03-25 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
